البلد: أستراليا
اللغة: الإنجليزية
المصدر: Department of Health (Therapeutic Goods Administration)
beclometasone dipropionate, Quantity: 0.1 mg/actuation
iNova Pharmaceuticals (Australia) Pty Ltd
Inhalation, pressurised
Excipient Ingredients: ethanol; norflurane
Inhalation
100 Doses, 200 Doses
(S4) Prescription Only Medicine
Prophylactic management of asthma.
Visual Identification: Colourless solution.; Container Type: Aerosol Can - Metered Dose; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius
Registered
1999-11-23
QVAR™ _AUTOHALER™ AND INHALER_ (queue-var auto-hailer and queue-var in-hailer) _Beclometasone dipropionate extrafine aerosol (beck-low-meth-a-zone die-pro-pee-one-ate)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about QVAR Autohaler and QVAR Inhaler. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking QVAR Autohaler and QVAR Inhaler against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT'S IN QVAR AUTOHALER AND QVAR INHALER The name of your medication is QVAR Autohaler and QVAR Inhaler. It contains an active ingredient called beclometasone dipropionate. Beclometasone dipropionate belongs to the corticosteroid family. The amount of medicine in each puff of QVAR 50 Autohaler and QVAR 50 Inhaler is 50 micrograms of beclometasone dipropionate, and 100 micrograms in each puff of QVAR 100 Autohaler and QVAR 100 Inhaler. Each QVAR Autohaler and QVAR Inhaler 200 dose contains at least 200 puffs. WHAT QVAR AUTOHALER AND QVAR INHALER ARE USED FOR QVAR Autohaler and QVAR Inhaler are designed so the medicine can be inhaled (breathed in) into the lungs to help manage asthma. Asthma causes the lining of your lungs to become inflamed (red and swollen), making it difficult for you to breathe. Beclometasone dipropionate acts directly on your air passages to reduce inflammation. This helps to improve your condition and to prevent asthma attacks from occurring. QVAR Autohaler and QVAR Inhaler are, therefore, known as a "PREVENTER" medicine. IT MUST BE USED EVERY DAY EVEN IF YOU HAVE NO SYMPTOMS. There is no evidence that QVAR Autohaler and QVAR Inhaler is addictive. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor اقرأ الوثيقة كاملة
1 AUSTRALIAN PRODUCT INFORMATION – QVAR™ (BECLOMETASONE DIPROPIONATE) AUTOHALER™ AND QVAR™ (BECLOMETASONE DIPROPIONATE) INHALER 1 NAME OF THE MEDICINE Beclometasone dipropionate 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Beclometasone dipropionate (BDP) is a white to creamy white, odourless powder; it is slightly soluble in water, very soluble in chloroform and freely soluble in acetone and alcohol. QVAR also contains ethanol and norflurane (HFA-134a), a propellant which does not contain chlorofluorocarbons (CFCs). Excipients with known effects: ethanol (alcohol) 11.85 % v/v. QVAR 50 Inhaler and Autohaler deliver 50 µg of BDP per inhalation. QVAR 100 Inhaler and Autohaler deliver 100 µg of BDP per inhalation. QVAR Autohaler is a breath actuated inhaler which automatically releases a metered dose of medication during inhalation through the mouthpiece and overcomes the need for patients to coordinate actuation with inspiration. QVAR Inhaler is a conventional press and breathe metered dose inhaler (P&B MDI). There are no differences in formulation between the Autohaler and the Inhaler products. QVAR contains BDP in solution, resulting in an extra fine aerosol. The aerosol droplets of QVAR are on average much smaller (Mass Median Aerodynamic Diameter (MMAD), MMAD range 0.8 to 1.2 microns) than the particle sizes delivered by CFC-suspension formulations (MMAD range 3.5 to 4 microns) or dry powder formulations (MMAD approximately 10 microns) of BDP. The smaller particle size for QVAR results in greater deposition in the airways and less deposition in the oropharynx than beclometasone products formulated in CFCs. Radiolabelled deposition studies demonstrated that for QVAR the majority of BDP (>55 % dose ex actuator) is deposited in the lungs and a small amount (< 35 % dose ex actuator) is deposited in the oropharynx. In contrast, approximately 4-7 % dose from the actuator of BDP formulated in chlorofluorocarbons (CFC-BDP) is deposited in the lungs and over 90 % is deposited in the oropharynx. The imaging data اقرأ الوثيقة كاملة